49 results
Page 2 of 3
S-8
fwzb9cw
21 Oct 19
Registration of securities for employees
4:26pm
8-K
EX-99.1
179z7le5hr37
10 Oct 19
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director
11:33am
8-K
EX-99.1
tdds4s4oo11tnhm
7 Aug 19
Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board
1:11pm
FWP
d4a9u sqywhl60xqj
5 Jun 18
Free writing prospectus
4:31pm
10-KT
agvrtv50waugc jtt
26 Mar 18
Annual report (with FYE transition)
12:00am
8-K
EX-99.1
xbisdfmhtlgh9n42lgma
18 Jul 16
Appoints Four Renowned Hepatitis B Experts; Carol L. Brosgart, M.D., to Serve as Chair of the Board
12:00am
8-K
EX-99.1
u9nnxrra
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
8-K
oj41ah70 flmesjrirk
16 Dec 14
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board Chair
12:00am
8-K
EX-99.1
u8c85q8
16 Dec 14
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board Chair
12:00am
DEF 14A
szk6cd8
27 Oct 14
Definitive proxy
12:00am
PRER14A
3ggt0
23 Oct 14
Preliminary revised proxy
12:00am
10-K
bho tmvpw
29 Sep 14
Annual report
12:00am